India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan

▴ India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan
India is among the top ten countries in the world with respect to the number of patents filed.

Union Minister of Science and Technology, Earth Sciences and Health & Family Welfare, Dr Harsh Vardhan yesterday informed the DST-CII India Portugal Technology Summit 2020 which is a flagship event with Portugal as a partner country, “In India, about 30 vaccines are in different stages of development. Two of them are in the most advanced stage of development - COVAXIN developed through ICMR-Bharat Biotech collaboration and COVISHIELD from the Serum Institute of India. Both are in the Phase-III clinical trial stage. Our premier institution – the Indian Council of Medical Research-is involved in their trial executions. India is also hosting clinical trials for all the major vaccine contenders. Serum Institute of India, the world’s largest vaccine manufacturer, is conducting trials for the vaccine developed by Oxford University. ZydusCadila is also conducting a Ph2 trial of an indigenous DNA Vaccine. One of our pharma giants, Dr Reddy’s Laboratories, will distribute the Russian vaccine in India after conducting final-stage human trials and receiving regulatory approval”.

The Science & Technology Minister disclosed that India is among the top ten countries in the world with respect to the number of patents filed. Highlighting India’s efforts to fight the challenge of COVID, he said: “More than 100 start-ups supported by the Government have provided innovative products and solutions to overcome challenges posed by COVID-19”.

Dr Harsh Vardhan stated “The Summit is a reflection of the effective partnership between the Government and industry for developing a robust technology ecosystem for the country”. The Minister said, “The next iteration of this collaboration will be to encourage new solutions based on cutting edge technologies such as Machine Learning and Artificial Intelligence”.

He dwelt on India-Portugal relations in various fields over long years. Dr Harsh Vardhan expressed the hope that the interactions offer a good opportunity for the participating companies to explore prospects for bilateral investments across sectors such as healthcare, water, agriculture, energy and Information Technologies.

Prof Manuel Heitor, Minister of Science, Technology and Higher Education, Government of Portugal, who was the Guest of Honour delivered the Keynote Address. He said, “ These are times of solidarity. Our ties with India are strong. We need to rely on knowledge to be out of this crisis together”.

Prof. Ashutosh Sharma, Secretary, Department of Science and Technology (DST), Government of India, outlined that during all these years, the summit has facilitated co-creation of knowledge, two-way technology transfer, collaborative R&D projects and enhanced market access between India and the partner country’s industry and research institutes. He said that the S&T ecosystem has blossomed in India by the gradually increasing focus of its policy regime, an impetus that has been ably supported by the years of economic reforms and landmark initiatives.

Over the past 26 years, the Department of Science and Technology (DST), Government of India has been co-organizing the Technology Summit in partnership with Confederation of Indian Industry (CII). The summit has benefitted immensely the Indian industry and academic & research institutions by forging collaborations with global partners, including policymaking that has triggered the private sector’s investment in R&D and technology significantly. Spain, South Korea, the UK and Italy have also participated in the summits in the past.

Tags : #DrHarshVardhan #IndiaFightsCorona #LatestPharmaNews8thDec #LatestNewsonCOVIDVaccine8thDec #ICMR-Bharat-Biotech #ZydusCadila #DrReddysLab

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

HR leaders ready to shape India's future workforce - XLRI and Leadup Universe seminar in PuneNovember 05, 2024
Nestlé India and SM Sehgal Foundation celebrate 5 years of Project Vriddhi November 05, 2024
Why Tuberculosis Is Still the World’s Leading Killer in 2024 And How We’re Failing to Stop ItNovember 05, 2024
Crompton Launches the Nigella Pro Mixer Grinder to Revolutionize Kitchen ConvenienceNovember 05, 2024
Invisible Shadows: The Growing Crisis of Corneal Blindness in IndiaNovember 05, 2024
Thai AirAsia Entrusts Çelebi India with Ground Handling for New Hyderabad- Bangkok Flights, Signalling Further India Expansion November 05, 2024
Thai AirAsia Entrusts Çelebi India with Ground Handling for New Hyderabad- Bangkok Flights, Signalling Further India Expansion November 05, 2024
Discover 5 Platforms That Turn Your Pennies into PowerhousesNovember 04, 2024
Breathless in the Capital: Post-Diwali Smog Triggers Health Alarms in DelhiNovember 04, 2024
Is Your Diet Fuelling Your Disease? The Shocking Link Between Oil and Multiple SclerosisNovember 04, 2024
Unmasking the Danger Within: The Alarming Rise of Stomach Cancer in IndiaNovember 04, 2024
Hospital-acquired infections are fuelling antimicrobial resistance October 30, 2024
Transforming Patient Care: HealthTech Startups Making Waves in HealthcareOctober 30, 2024
Hospital-acquired infections are fuelling antimicrobial resistance October 30, 2024
Impressive Growth & Margin Expansion 237% YoY Surge in Net ProfitsOctober 29, 2024
Ramaiah Memorial Hospital Announces the Launch of its Comprehensive State-of-the-art Ramaiah Stroke Center on World Stroke Day October 29, 2024
CarDekho Group's New Auto Segment’s Festive Trend Report: SUVs Lead the Way with a 43% YoY Traffic Increase Across All Sub-SegmentsOctober 29, 2024
World Stroke Day by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.October 29, 2024
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024October 29, 2024
AI Gone Wild? Why OpenAI’s Whisper - Transcription Tool used in Hospitals Might Be Putting Lives at RiskOctober 29, 2024